Volunteers may soon receive a call to the UK for a Kovid transition


Alex Greer says he puts himself directly in the path of the coronovirus, as he gets blinded by illness in the pub in the evening or with friends. This is a scenario that may soon become a reality.

The UK is moving closer to carrying out studies that will intentionally infect healthy people with the virus, to help researchers discover the Kovid-19 vaccine, and thousands of volunteers such as Greer at the University of Durham in Northeast England in chemistry. Students are ready to leave. . Open Orphan plc, parent of human challenge testing expert hVivo said To test Kovid shots in conversations with potential customers including the UK.

Such studies can help accelerate the development of vaccines and provide scientists with new information in a disease that has spread to more than 37 million people globally, but participants are at a risk. Will expose for which there is no cure. Many questions about the virus – which volunteers are likely to Spraying in their nose – remain unanswered. Even the youth could face threats.

The 20-year-old Greer said, “I can’t lie and it doesn’t cross my mind.”, The long-term results of Kovid have not yet been fully researched and need to be addressed. But I think the potential successes of the test outweigh that small risk. ”
Despite recent conflicts in the treatment of Kovid-19, experts disagree on whether the challenge test is appropriate. One uncertainty is that some young and otherwise healthy people experience complications for months after experiencing mild symptoms. Seema Shah, a biologist at Lurie Children’s Hospital of Chicago and Northwestern University.

Crossing a line

“It would actually cross a line that people have drawn in terms of being morally acceptable to study the challenge,” she said. “In the past, it has been about diseases we know a lot about. We are still learning a lot about Kovid-19. “

In UK Vaccine Closure Infects Healthy People To Covid To Ad Vaccine Efforts

A topic injected as part of the first human coronavirus vaccine trials in Britain, untested by the University of Oxford in April.

Photographer: Oxford University Pool via AP Photo

Companies like AstraZeneca plc – a partner in the experimental coronavirus vaccine at the University of Oxford – suggested earlier this year that a decline in infection rates could make it harder to conduct traditional tests that wait for people in the wider community to naturally catch the virus . Yet Kovid is spreading, allowing many projects to be sprayed in the final stages of clinical trials.

Read more: Pfizer’s Kovid vaccine trial may beat rivals in early May

    .

Leave a Reply

Your email address will not be published.